NPI: 1881738037 · BRYN MAWR, PA 19010 · Professional Counselor · NPI assigned 02/19/2007
Authorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
| Authorized Official | PINCINCE, DEBORAH (ADMINISTRATOR) |
| NPI Enumeration Date | 02/19/2007 |
Other providers sharing the same authorized official: PINCINCE, DEBORAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 369 | $15K |
| 2019 | 738 | $19K |
| 2020 | 29,013 | $286K |
| 2021 | 168,420 | $2.24M |
| 2022 | 61,947 | $624K |
| 2023 | 9,719 | $95K |
| 2024 | 8,557 | $59K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 167,631 | 147,679 | $1.72M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 35,367 | 31,438 | $862K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 7,708 | 6,774 | $214K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 26,621 | 21,647 | $206K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,535 | 2,993 | $84K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,930 | 1,710 | $78K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,688 | 2,400 | $74K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 777 | 696 | $37K |
| 86580 | 8,740 | 7,733 | $11K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,337 | 1,085 | $8K |
| 90674 | 1,976 | 1,938 | $8K | |
| 90734 | 189 | 173 | $8K | |
| 90686 | 1,370 | 1,309 | $7K | |
| 90715 | 814 | 778 | $5K | |
| 90746 | 320 | 310 | $4K | |
| 90682 | 390 | 379 | $3K | |
| 99201 | 77 | 73 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 135 | 109 | $1K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 28 | 24 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 103 | 54 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 127 | 120 | $878.76 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 42 | 30 | $876.57 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 211 | 209 | $756.00 |
| 90661 | 283 | 252 | $593.34 | |
| 0031A | 33 | 33 | $578.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 19 | 13 | $516.08 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 150 | 131 | $446.70 |
| 0001A | 354 | 351 | $288.00 | |
| 80061 | Lipid panel | 37 | 26 | $99.40 |
| 0004A | 361 | 345 | $80.00 | |
| 0064A | 15 | 15 | $40.00 | |
| 91322 | 169 | 162 | $40.00 | |
| 0124A | 38 | 38 | $40.00 | |
| 0071A | 157 | 157 | $40.00 | |
| 3008F | 2,101 | 1,678 | $25.00 | |
| 3074F | 2,278 | 1,834 | $25.00 | |
| 1036F | 4,871 | 3,781 | $25.00 | |
| 1159F | 1,398 | 1,164 | $25.00 | |
| 3078F | 1,689 | 1,332 | $25.00 | |
| 1160F | 1,832 | 1,529 | $25.00 | |
| 90656 | 94 | 88 | $0.00 | |
| 0072A | 101 | 101 | $0.00 | |
| 3079F | 271 | 207 | $0.00 | |
| 90716 | 17 | 17 | $0.00 | |
| 3075F | 29 | 24 | $0.00 | |
| 0011A | 14 | 14 | $0.00 | |
| 90619 | 53 | 53 | $0.00 | |
| 0081A | 19 | 19 | $0.00 | |
| 0082A | 16 | 16 | $0.00 | |
| 90651 | 12 | 12 | $0.00 | |
| 0002A | 197 | 197 | $0.00 | |
| 91320 | 15 | 12 | $0.00 | |
| 90750 | 24 | 24 | $0.00 |